• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 30-05-2026: Outcome of Board Meeting

    30-05-2026 | 07:16 pm

    Biofil Chemicals & Pharma Board approved Q4 & FY26 standalone audited results. FY26 revenue dropped to ₹28.40 Cr, but net profit jumped to ₹2.79 Cr (FY25: ₹0.56 Cr) mainly due to asset disposal. Factory renovation impacted operations, causing lower turnover.

    No comments yet. Be the first to comment!

    All announcements from Biofil Chemicals & Pharmaceuticals Limited